$PCT

PureCycle Technologies Stock Falls 16% Over Pricing Of Concurrent Public Offerings Worth $395 Mln

PureCycle Technologies’ shares fell about 16% after the company priced concurrent underwritten public offerings totaling $250 million in 4.75% convertible senior notes due 2032 and 17,661,388 shares of common stock at $8.21 per share, according to the announcement. The stock was trading around $8.28, down from $9.89 at the prior close on Nasdaq.

Original reporting
Published Jun 11, 2026, 5:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 11, 2026, 6:16 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMarket movers
Primary signal
$PCT
Bearish
high confidence
Mentioned
$PCT
Relevance
8/10
alphai data visualization · based on rttnews.com
Decision brief

The 30-second read

$PCTBearishMed
01

Why it matters

The definitive pricing (notes + equity at $8.21/share) provides a concrete dilution and financing catalyst, explaining the sharp immediate decline.

02

Market read

A priced, dilutive capital raise is the direct driver of the day’s move, making it actionable for positioning around offering execution and dilution expectations.

03

What to watch

The article doesn’t state use of proceeds, underwriting terms, or any hedging/convertible conversion dynamics that could affect longer-term dilution risk.

Relevance 8/10Novelty 8/10Timing: Thursday morning after offering pricing announcement

Background

PureCycle announced previously underwritten concurrent offerings of convertible notes and common stock; this report covers the final pricing terms.

Company-level read

Ticker impact

$PCTBearishHigh confidence
Context

PureCycle priced $250M of 4.75% convertible notes due 2032 and 17.66M common shares at $8.21, driving a ~16% stock drop.

Expected impact

Bearish near-term; expect volatility around deal execution and any follow-on dilution/convertible overhang.

Evidence & confidence

The article reports the definitive pricing terms of a sizable concurrent equity + convertible offering and ties it to the immediate ~16% decline.

Market effects

Signals continued reliance on capital markets for clean-tech/industrial recycling names; may raise dilution expectations for similar pre-profit issuers.

Primarily impacts US small/mid-cap growth sentiment on Nasdaq.

Limited; deal is company-specific with no stated cross-border counterparties.

Counterpoint

Convertibles can extend runway and reduce immediate cash burn; if proceeds fund commercialization, the selloff may be overdone.

Key entities

  • PureCycle Technologies, Inc.

    Subject of the concurrent $250M convertible notes and common stock offering pricing.

  • 4.75% convertible senior notes due 2032

    $250.0M aggregate principal amount priced as part of the financing.

  • Common stock offering

    17,661,388 shares priced at $8.21 per share concurrently.

Related articles

$PCTMed

PureCycle (PCT) Q2 2026 Earnings Call Transcript

PureCycle Technologies (PCT) reported Q2 2026 revenue of $4.5 million, up 173% year over year, with sequential growth for the sixth quarter. The company posted a net loss of $142.2 million and negative adjusted EBITDA of $31.7 million. It ended with $236.9 million liquidity and raised $432 million net via convertible notes and common stock, while repurchasing $216 million of 7.25% convertibles. Management raised 2026 project spend guidance to $45-$50 million and cited progress on Ironton turnaro

$PCTMed

PureCycle Technologies Q2 Earnings Call Highlights

PureCycle Technologies reported Q2 revenue of about $4.5M and an operating loss of $41.3M, with adjusted EBITDA of -$31.7M. The company cited commercial progress with Procter & Gamble, including Downy and Tide cap production timelines, and New Jersey recycled-content approvals. It targets Ironton cash breakeven in 2H 2026, expects Thailand ground in 2H 2026 and operations in 2028, and ended Q2 with $236.9M liquidity.

$PCTMed

PureCycle Technologies, Inc. (PCT): Results of Operations and Financial Condition

PureCycle Technologies, Inc. (PCT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 pct-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 PureCycle Technologies Reports Second Quarter 2026 Results • First P&G commercial resin deliveries began, with select Downy detergent caps now in commercial production • Revenue of $4.5 million, up approximately 173% year-over

$PCTMedAI 8/10

PureCycle Announces Closing of Concurrent Public Offerings of Convertible Senior Notes and Common Stock

PureCycle Technologies (NASDAQ: PCT) said it closed concurrent public offerings of $287.5 million aggregate principal 4.75% convertible senior notes due 2032 and 19,854,000 shares of common stock, including full underwriter over-allotments. Morgan Stanley was sole bookrunner. Net proceeds were about $432.5 million; PureCycle plans to use about $246.3 million to repurchase $216.0 million of its 7.25% Green Convertible Notes due 2030 and the rest for other purposes.

$PCTMedAI 8/10

PureCycle Announces Pricing of Concurrent Public Offerings of 4.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $395.0 Million

PureCycle Technologies priced concurrent underwritten offerings: $250.0 million aggregate principal of 4.75% convertible senior notes due 2032 and 17,661,388 shares of common stock at $8.21 per share, for $395.0 million gross proceeds, according to the company. Net proceeds are estimated at ~$242.0 million (notes) and ~$137.1 million (stock). Expected to close around June 15, 2026. Proceeds will fund repurchases of its 7.25% green convertible notes due 2030 and general purposes.

$PCTMedAI 9/10

PureCycle Announces Proposed Concurrent Public Offerings of Convertible Senior Notes and Common Stock

PureCycle Technologies (Nasdaq: PCT) said it has started underwritten concurrent offerings: $250.0 million of convertible senior notes due 2032 and $145.0 million of common stock. It plans 30-day underwriter over-allotment options for up to $37.5 million more notes and $18.75 million more shares. Net proceeds would fund repurchases of its 7.25% green convertible notes due 2030 and general corporate use, with Morgan Stanley as sole bookrunner.